EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.23.47 | medicine | potential target for chemotherapy of virus infection and associated diseases, essential for maturation of infectious virions, development of drugs against the protease should be effective against HIV-2 | Human immunodeficiency virus 2 |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.23.47 | cloned and expressed in Escherichia coli JM-101, F' and X90 | Human immunodeficiency virus 2 |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.4.23.47 | crystallized by hanging drop method in complex with a reduced amide inhibitor, BI-LA-398 | Human immunodeficiency virus 2 |
EC Number | General Stability | Organism |
---|---|---|
3.4.23.47 | activity is lost during purification and storage | Human immunodeficiency virus 2 |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.23.47 | 0.74 | - |
NH2-ATLNFPSPW-COOH | pH 5.5, 37°C | Human immunodeficiency virus 2 | |
3.4.23.47 | 0.95 | - |
NH2-ATLNFPSPW-COOH | pH 5.5, 37°C, mutant K7Q | Human immunodeficiency virus 2 |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.23.47 | GAG precursor protein of HIV-2 + H2O | Human immunodeficiency virus 2 | - |
? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.23.47 | Human immunodeficiency virus 2 | - |
mutant K7Q | - |
3.4.23.47 | Human immunodeficiency virus 2 | - |
human immunodeficiency virus type 2 | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.23.47 | mutant K7Q, autoproteolysis | Human immunodeficiency virus 2 |
3.4.23.47 | recombinant enzyme | Human immunodeficiency virus 2 |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.23.47 | GAG precursor protein of HIV-2 + H2O | - |
Human immunodeficiency virus 2 | ? | - |
? | |
3.4.23.47 | additional information | cleavage sites identified by amino-terminal sequence analysis are F3-S4, Y14-I15, G35-I36, G52-F53, M76-T77, L90-T91 | Human immunodeficiency virus 2 | ? | - |
? | |
3.4.23.47 | NH2-ATLNFPSPW-COOH + H2O | - |
Human immunodeficiency virus 2 | ? | - |
? |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.23.47 | 3 | - |
NH2-ATLNFPSPW-COOH | pH 5.5, 37°C | Human immunodeficiency virus 2 | |
3.4.23.47 | 4.33 | - |
NH2-ATLNFPSPW-COOH | pH 5.5, 37°C, mutant K7Q | Human immunodeficiency virus 2 |